A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer

References

• Arbyn M, Castellsague X, de Sanjose S, . (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol 22:2675–86.
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, . (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–53.
   PubMed Web of Science ®Google Scholar
• Peters WA III, Liu PY, Barrett RJ II, . (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–13.
   PubMed Web of Science ®Google Scholar
• Morris M, Eifel PJ, Lu J, . (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–43.
   PubMed Web of Science ®Google Scholar
• Keys HM, Bundy BN, Stehman FB 3rd, . (1999). Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–61.
   PubMed Web of Science ®Google Scholar
• Whitney CW, Sause W, Bundy BN Jr, . (1999). Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–48.
   PubMed Web of Science ®Google Scholar
• Lutgens L, van der Zee J, Pijls-Johannesma M, . (2010). Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. Cochrane Database Syst Rev CD006377.
   Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, . (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–25.
   PubMed Web of Science ®Google Scholar
• Harima Y, Nagata K, Harima K, . (2001). A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17:97–105.
   PubMed Web of Science ®Google Scholar
• Urano M, Kahn J, Majima H, . (1990). The cytotoxic effect of cis-diamminedichloroplatinum(II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int J Hyperthermia 6:581–90.
   PubMed Web of Science ®Google Scholar
• Rietbroek RC, Schilthuis MS, Bakker PJ, . (1997). Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79:935–43.
   PubMed Web of Science ®Google Scholar
• de Wit R, van der Zee J, van der Burg ME, . (1999). A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 80:1387–91.
   PubMed Web of Science ®Google Scholar
• Westermann A, Mella O, Van Der Zee J, . (2012). Long-term survival data of triple modality treatment of stage IIB–III–IVA cervical cancer with the combination of radiotherapy, chemotherapy and hyperthermia – an update. Int J Hyperthermia 28:549–3.
   PubMed Web of Science ®Google Scholar
• Benedet JL, Bender H, Jones H III, . (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–62.
   PubMed Web of Science ®Google Scholar
• Bethesda MD. (1985). Dose and volume specification for reorting intracavitary therapy in gynecology. International Commission of Radiation Units and Measurements.
   Google Scholar
• Fatehi D, van der Zee J, de Bruijne M, . (2007). RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible. Int J Hyperthermia 23:623–43.
   PubMed Web of Science ®Google Scholar
• Trotti A, Byhardt R, Stetz J, . (2000). Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47:13–47.
   PubMed Web of Science ®Google Scholar
• Kaplan E, Meier P. (1958). Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457–81.
   Web of Science ®Google Scholar
• Mantel N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–70.
   PubMedGoogle Scholar
• Cox DR. (1992). Regression models and life-tables. Breakthroughs in statistics. New York: Springer; p. 527–41.
   Google Scholar
• Cox D. (1958). The regression analysis of binary sequences (with discussion). J R Stat Soc B 20:215–42.
   Google Scholar
• Vale C. (2008). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26:5802–12.
   PubMed Web of Science ®Google Scholar
• Vasanthan A, Mitsumori M, Park JH, . (2005). Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 61:145–53.
   PubMed Web of Science ®Google Scholar
• Zolciak-Siwinska A, Piotrkowicz N, Jonska-Gmyrek J, . (2013). HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study. Radiother Oncol 109:194–9.
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Heydon K, Mutch DG, . (2001). Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51:982–7.
   PubMed Web of Science ®Google Scholar
• Grogan M, Thomas GM, Melamed I, . (1999). The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86:1528–36.
   PubMed Web of Science ®Google Scholar
• Bishop AJ, Allen PK, Klopp AH, . (2015). Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys 91:196–205.
   PubMed Web of Science ®Google Scholar
• Westermann AM, Jones EL, Schem BC, . (2005). First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 104:763–70.
   PubMed Web of Science ®Google Scholar
• Feldmann HJ, Seegenschmiedt MH, Molls M. (1995). Hyperthermia – its actual role in radiation oncology. Part III: clinical rationale and results in deep seated tumors. Strahlenther Onkol 171:251–64.
   PubMedGoogle Scholar
• Harima Y, Nagata K, Harima K, . (2000). Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma. Cancer 88:132–8.
   PubMed Web of Science ®Google Scholar
• Eppink B, Krawczyk PM, Stap J, . (2012). Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies. Int J Hyperthermia 28:509–17.
   PubMed Web of Science ®Google Scholar
• Frey B, Weiss EM, Rubner Y, . (2012). Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 28:528–42.
   PubMed Web of Science ®Google Scholar